Emergence of SARS-CoV-2 Variants and Impact on IVD Testing - Emergence of SARS-CoV-2 Variants and Impact on IVD Testing - POCTRN
Latest News
Emergence of SARS-CoV-2 Variants and Impact on IVD Testing
Speakers:
Richard Creager, PhD
Co-Founder & Partner, NaviDx LLC
Eric Lai, PhD
Ex-SVP at Takeda Pharmaceutical and Head of R&D at Gen-Probe Diagnostics
This webinar took place on March 23, 2021: